K Number
K161980
Device Name
Fuselier Intraoral Nighttime Device (FIND)
Date Cleared
2017-02-07

(204 days)

Product Code
Regulation Number
872.5570
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
A patient specific mandibular repositioning device intended to reduce or alleviate night-time snoring and mild to moderate obstructive sleep apnea in adult patients 18 years or older.
Device Description
The Fuselier Intraoral Nighttime Device (FIND) is a patient specific oral device intended to mitigate night-time snoring and mild to moderate obstructive sleep apnea. The function of the FIND is to continuously hold the mandible in an advanced position to prevent the tongue from compressing against the oropharyngeal wall keeping the airway open during sleep. The principle of advancing a lower tray is to advance the mandible for the treatment of night-time snoring and / or mild to moderate obstructive sleep apnea.
More Information

No
The summary describes a mechanical oral device and does not mention any AI or ML components or functions.

Yes
The device is intended to alleviate or reduce obstructive sleep apnea and snoring, which are medical conditions, by holding the mandible in an advanced position to keep the airway open during sleep. This action directly addresses a health problem, qualifying it as therapeutic.

No

The device description clearly states its purpose is to reduce or alleviate snoring and sleep apnea by repositioning the mandible, which is a treatment function, not a diagnostic one.

No

The device description clearly states it is a "patient specific oral device" and describes its physical function of holding the mandible in an advanced position. The performance studies focus on mechanical properties and material biocompatibility, which are characteristic of a physical medical device, not software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information for diagnosis, monitoring, or screening.
  • Device Function: The Fuselier Intraoral Nighttime Device (FIND) is a physical device worn in the mouth. Its function is to mechanically reposition the mandible to keep the airway open. It does not analyze any biological samples.
  • Intended Use: The intended use is to reduce or alleviate snoring and sleep apnea by physically altering the position of the jaw. This is a mechanical intervention, not a diagnostic test performed on a sample.

The information provided clearly describes a physical, patient-specific oral appliance used for treatment, not for analyzing biological samples for diagnostic purposes.

N/A

Intended Use / Indications for Use

A patient specific mandibular repositioning device intended to reduce or alleviate night-time snoring and mild to moderate obstructive sleep apnea in adult patients 18 years or older.

Product codes (comma separated list FDA assigned to the subject device)

LRK

Device Description

The Fuselier Intraoral Nighttime Device (FIND) is a patient specific oral device intended to mitigate night-time snoring and mild to moderate obstructive sleep apnea. The function of the FIND is to continuously hold the mandible in an advanced position to prevent the tongue from compressing against the oropharyngeal wall keeping the airway open during sleep.

The principle of advancing a lower tray is to advance the mandible for the treatment of night-time snoring and / or mild to moderate obstructive sleep apnea.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

18 years or older.

Intended User / Care Setting

Home, Dental offices, and Sleep laboratories

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Real-time Aging: The FIND has been used in a private dental practice for more than 1 year without device failures. The results of this experience support the substantial equivalence of the FIND for its proposed intended use to that of the predicate device. The observations support: Cleaning via rinsing with water and use of a toothbrush, Mechanical and durability after 1 year real-time use, Effects of aging do not alter the performance of the device.

Mechanical Performance: Flexural and breakage strength testing was performed on the subject device and the predicate. The construction and design performance were tested and found to be substantially equivalent. Flexural strength: Angle of deflection – 0.85 degrees, 77 lbs. to damage. Breakage Strength: 77 lbs. to damage. The comparative testing to the predicate demonstrated equivalence in performance.

Biocompatibility / Materials: The materials in contact with the patient have been cleared for the intended use of dental trays. The materials for the trays are identical to K896103 - IVOCap materials for the intended purpose of dental trays.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K972061 – Keith Thornton, DDS – Thornton Oral Appliance (TOA)

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

K090436 - Orthoplant Dental - Airwayease MAS, K896130 - Ivoclar Vivadent - SR Ivocap Polymer

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 872.5570 Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea.

(a)
Identification. Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea are devices that are worn during sleep to reduce the incidence of snoring and to treat obstructive sleep apnea. The devices are designed to increase the patency of the airway and to decrease air turbulence and airway obstruction. The classification includes palatal lifting devices, tongue retaining devices, and mandibular repositioning devices.(b)
Classification. Class II (special controls). The special control for these devices is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA.”

0

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is a stylized image of a bird or eagle, formed by three overlapping profiles of human faces.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

February 7, 2017

Fuselier Enterprises, LLC Paul Dryden Consultant 2051 Mohican Trail Maitland, Florida 32751

Re: K161980 Trade/Device Name: Fuselier Intraoral Nighttime Device (find) Regulation Number: 21 CFR 872.5570 Regulation Name: Intraoral Devices For Snoring And Intraoral Devices For Snoring And Obstructive Sleep Apnea Regulatory Class: Class II Product Code: LRK

Dear Paul Dryden:

Dated: January 4, 2017 Received: January 6, 2017

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in

1

the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely.

Michael J. Ryan -S

for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

510(k) Number (if known)

K161980

Device Name

Fuselier Intraoral Nighttime Device

Indications for Use (Describe)

A patient specific mandibular repositioning device intended to reduce or alleviate night-time snoring and mild to moderate obstructive sleep apnea in adult patients 18 years or older.

Type of Use (Select one or both, as applicable)
XX Prescription Use (Part 21 CFR 801 Subpart D)Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.qov

"An agency may not conduct or sponsor, and a person is not respond to, a collection of information unless it displays a currently valid OMB number."

FORM FDA 3881 (8/14)

Page 1 of 1

PSC Publishing Services (301) 443-6740 EF

Expiration Date: January 31, 2017 See PRA Statement below.

3

Fuselier Enterprises, LLC 2051 Mohican Trail Maitland, FL 32751

Official Contact:Brian Fuselier, Owner
Proprietary or Trade Name:Fuselier Intraoral Nighttime Device
Common/Usual Name:Device, Anti-Snoring
Classification Name:LRK - Device, anti-snoring, Intraoral devices for snoring and
intraoral devices for snoring and obstructive sleep apnea
21 CFR 872.5570, Class 2
Predicate Device:K972061 – Keith Thornton, DDS – Thornton Oral Appliance
(TOA)
Reference Devices:K090436 - Orthoplant Dental - Airwayease MAS
K896130 - Ivoclar Vivadent - SR Ivocap Polymer

Device Description:

The Fuselier Intraoral Nighttime Device (FIND) is a patient specific oral device intended to mitigate night-time snoring and mild to moderate obstructive sleep apnea. The function of the FIND is to continuously hold the mandible in an advanced position to prevent the tongue from compressing against the oropharyngeal wall keeping the airway open during sleep.

The principle of advancing a lower tray is to advance the mandible for the treatment of night-time snoring and / or mild to moderate obstructive sleep apnea.

Indications for Use

A patient specific mandibular repositioning oral appliance intended to reduce or alleviate night-time snoring and mild to moderate obstructive sleep apnea in adult patients 18 years or older.

Contraindications

The following contraindications are noted in the labeling. These are typical of oral appliances for the proposed indications for use and suggested by FDA's guidance document.

The device is contraindicated for patients who:

  • have central sleep apnea
  • have severe respiratory disorders ●
  • have loose teeth or advanced periodontal disease
  • have loose dental work
  • oral conditions which would be adversely affected by wearing dental appliances
  • full denture user
  • . are under 18 years of age

Warnings

Use of this device may cause:

  • tooth movement
  • changes in dental occlusion ●
  • gingival soreness

4

510(k) Summary Page 2 of 6 4-Jan-17

  • tooth soreness ●
  • pain or soreness to the temporomandibular joint ●
  • obstruction of oral breathing
  • excessive salivation
  • excessive dry mouth
  • loosening of dental restorations
  • . loosening of teeth

Environment of Use

Home, Dental offices, and Sleep laboratories

Predicate Device Comparison:

We selected a predicate for the Fuselier Intraoral Nighttime Device and present the similarities in Table 1.

Table 1 - Predicate Device Comparison
---------------------------------------------
Subject DevicePredicate
Fuselier Intraoral Nighttime DeviceThornton Oral Appliance (TOA)
K972061
Product ClassificationLRK – device, anti-snoring
Intraoral devices for snoring and
intraoral devices for snoring and
obstructive sleep apneaLRK - device, anti-snoring
Intraoral devices for snoring and
intraoral devices for snoring and
obstructive sleep apnea
Attributes
Indications for UseA patient specific mandibular
repositioning oral appliance intended
to reduce or alleviate night-time
snoring and mild to moderate
obstructive sleep apnea in adult
patients 18 years or older.The TOA is intended to reduce or
alleviate nighttime snoring and
obstructive sleep apnea, OSA.
Environments of useHome, dental and Physician offices,
Sleep laboratoriesHome, dental and Physician offices,
Sleep laboratories
Patient PopulationAdult patients 18 years and olderAdult patients 18 years and older
Contraindicationshave central sleep apnea have severe respiratory disorders have loose teeth or advanced periodontal disease are under 18 years of agehave central sleep apnea have severe respiratory disorders have loose teeth or advanced periodontal disease are under 18 years of age
PrescriptionPrescription usePrescription use
Single patient, multi-useYesYes
Principle of operation / means of
mandibular advancementAdjustment of the relative position of
the trays by the use of an adjustable
post that holds the mandible forward
and maintains mandibular
advancement thus enlarging the
airway. The vertical opening of the
jaw is not fixed in a single positionAdjustment of the relative position of
the trays by the use of hook which
pulls the mandible forward and
maintains mandibular advancement
thus enlarging the airway. The
vertical opening of the jaw is not fixed
in a single position

5

510(k) Summary Page 3 of 6

4-Jan-17
Subject Device
Fuselier Intraoral Nighttime DevicePredicate
Thornton Oral Appliance (TOA
K972061
Design
Patient specific traysYesYes
Allows lateral and vertical movementYesYes
User can breathe through their mouthYesYes
Maximum adjustment by the user8 mm8 mm
Adjustment method for setting the
amount of protrusionAdjustable screw/post holds the lower
tray forwardHook pulls the lower tray forward
Works by holding lower jaw forwardYesYes
Cleaned by simple rinsing with water
and toothbrushYesYes
Materials and BiocompatibilitySurface contact
Mucosal
Prolonged duration per FDA Guidance
for intraoral appliancesSurface contact
Mucosal
Prolonged duration per FDA
Guidance for intraoral appliances
Performance Testing
Material PropertiesPerformance testing related to torque
and tensile strength was performed
and compared to the predicateUse of standard dental tray material
Flexural Strength
Breakage StrengthAngle of deflection – 0.85 degrees
77 lbs. to damageAngle of deflection - 1.25 degrees
70 lbs. to damage
Cleaning and Effects of AgingPrivate clinical practice of 1 year with
150 patients has demonstrated that the
FIND does not degrade with time,
cleaning or ageData not available

Discussion of Substantial Equivalence to the Predicate

The Fuselier Intraoral Nighttime Device is viewed as substantially equivalent to the predicate device because:

Indications - Similar to predicate - Thornton Oral Appliance - K972061. Indicated for treating nighttime snoring and mild to moderate obstructive sleep apnea (OSA).

Discussion – The indications for use between the subject device and predicate are similar and therefore they can be found as substantially equivalent.

Technology / Principle of Operation - Similar to predicate - Thornton Oral Appliance - K972061. Both devices use separate patient specific trays with a means to advance the mandible / lower jaw. Discussion - Both devices use separate patient specific trays with a means to advance the mandible / lower jaw are similar and therefore they can be found as substantially equivalent.

Environment of Use - Similar to predicate - Thornton Oral Appliance - K972061. They are used in Home, Dental and Physician offices, Sleep laboratories.

Discussion - Both devices have the same environments of use and therefore they can be found as substantially equivalent.

Patient Population - Identical to predicate - Thornton Oral Appliance - K972061. 18 years and older

6

510(k) Summary Page 4 of 6 4-Jan-17

Discussion - The patient population is identical and therefore they can be found as substantially equivalent.

Non-clinical performance testing

Real-time Aging

The FIND has been used in a private dental practice for more than 1 year without device failures. The results of this experience support the substantial equivalence of the FIND for its proposed intended use to that of the predicate device.

The observations support:

  • Cleaning via rinsing with water and use of a toothbrush ●
  • Mechanical and durability after 1 year real-time use
  • Effects of aging do not alter the performance of the device ●

Mechanical Performance

We performed flexural and breakage strength testing on the subject device and the predicate and the construction and design performance were tested and found to be substantially equivalent. Discussion - We evaluated the strength of the tray materials and design based upon its intended use and flexural and breakage strength were the key factors to evaluate. Flexural strength saw the FIND to be slightly strong. less angular deflection under torque and the breakage strength – FIND had a slightly high force need before damage was observed. The comparative testing to the predicate demonstrated equivalence in performance.

Biocompatibility / Materials

The materials in contact with the patient have been cleared for the intended use of dental trays. The materials for the trays are identical to K896103 - IVOCap materials for the intended purpose of dental trays. In addition, the reference device, Orthoplant Dental Lab Airwayease MAS, K090436. utilizes the identical material for their oral appliance.

Clinical

Based upon Fuselier Intraoral Nighttime Device design concept, it was determined that no clinical testing would be required as we are identical in this principle of operation and technology as well as performance specification, namely maximum advancement distance. Also, the specifications of the ability to advance the lower tray are the same and the maximum advancement is similar to the predicate.

Discussion of Differences

The primary difference between the Fuselier Intraoral Nighttime Device and the predicate is the coupling system that holds the movable lower jaw in a forward position. This difference does not raise new concerns of substantial equivalence to the predicate device.

As presented in the above table, the proposed Fuselier Intraoral Nighttime Device is substantially equivalent to the identified predicate. The Fuselier Intraoral Nighttime Device and predicate are patient specific upper and lower trays, with a means of advancing the mandible to treat mild to moderate obstructive sleep apnea and snoring.

As indicated and discussed above, the fundamental features, indications for use, environment of use are identical to the predicates and thus the proposed Fuselier Intraoral Nighttime Device oral

7

510(k) Summary Page 5 of 6 4-Jan-17

appliance can be found to be substantially equivalent to the listed predicate - Thornton Oral Appliance - K972061.

We have also included reference devices and Table 2 presents the comparison to the subject device.

K896130K090436FIND
Ivoclar VivadentOrthoplant DentalProposed Device
SR Ivocap PolymerAirwayease MAS
Intended UseFor the making of dental traysThe Airwayease MIAS is
intended to reduce or alleviate
night time snoring and mild to
moderate obstructive sleep
apnea.A patient specific mandibular
repositioning oral appliance
intended to reduce or alleviate
night-time snoring and mild to
moderate obstructive sleep apnea
in adult patients 18 years or older.
PopulationNo restrictions on population as
this is dental tray material onlyAdult patients 18 years or older
who have a problem with
snoring or obstructive sleep
apnea.Adult patients 18 years and older.
Environment of
UseDental applicationsThe device is initially fitted
under the supervision of a
licensed practitioner (dentist or
physician) and is subsequently
used in either a home
environment or in a sleep
laboratory.Home, dental and Physician
offices, Sleep laboratories
MaterialsMaterial specifications sent
directly to FDAThe material composition of the
Airwayease MAS is identical to
the Ivocap Elastomer cleared in
K896130. No colorants or
additives have been added to
the originally cleared Ivocap
Elastomer.The material composition of the
FIND is identical to the Ivocap
Elastomer cleared in K090436. No
colorants or additives have been
added to the originally cleared
Ivocap Elastomer.
Technological
featuresThis is material to make dental
trays so there are technological
features that relate to the subject
device except that the material is
intended for dental applications
such as the subject device2 trays which are adjustable to
act as a mandibular repositioner2 trays which are adjustable to act
as a mandibular repositioner

Table 2 - Comparison of Reference Devices to Subject Device

Discussion of Reference Devices

We have selected reference devices which support the use of the intended materials for the intended use. K896130 is the Dental Tray material that has been used for many types of dental trays. K090436 specifically is an intra-oral appliance with the same intended use, patient population, and environment of use that utilizes the identical materials.

There are no differences between the reference devices and the subject device that would raise concerns of substantial equivalence.

8

510(k) Summary Page 6 of 6 4-Jan-17

Substantial Equivalence Conclusion –

Based upon the performance testing and comparison to the legally marketed predicate device for indications for use, technology, and performance we have demonstrated that the FIND is substantially equivalent to the predicate device.